AKT1 and acute myeloid leukemia: Through the regulation of redox balance, modulation of Notch and PI3K/Akt signaling pathways, and enhancement of chemotherapy sensitivity, AZA has shown the potential to overcome key mechanisms of AML progression and chemoresistance.